Literature DB >> 17548037

Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment.

Elizabeth A Mittendorf1, Douglas B Evans, Jeffrey E Lee, Nancy D Perrier.   

Abstract

Pheochromocytomas are rare, catecholamine-secreting tumors arising most frequently in the chromaffin cells of the adrenal glands. Recent studies have suggested that genetic mutations are more frequent than previously appreciated in patients with these lesions. Advances continue to be made not only in the genetic evaluation of these patients but also in the biochemical confirmation and tumor localization. Surgery remains the definitive treatment, and advances in laparoscopic techniques as well as cortical-sparing procedures have reduced the morbidity associated with tumor resection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548037     DOI: 10.1016/j.hoc.2007.04.012

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  9 in total

1.  Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A.

Authors:  Sarah M Nielsen; Wendy S Rubinstein; Darcy L Thull; Michaele J Armstrong; Eleanor Feingold; Linwah Yip; Samuel A Tisherman; Sally E Carty
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 2.  Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.

Authors:  Ioannis Ilias; Chaitanya Divgi; Karel Pacak
Journal:  Semin Nucl Med       Date:  2011-09       Impact factor: 4.446

3.  Laparoscopic adrenalectomy: A single center experience.

Authors:  Suresh Kumar; Moley K Bera; Mukesh K Vijay; Arindam Dutt; Punit Tiwari; Anup K Kundu
Journal:  J Minim Access Surg       Date:  2010-10       Impact factor: 1.407

Review 4.  A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.

Authors:  Ioannis Ilias; Karel Pacak
Journal:  Nucl Med Biol       Date:  2008-08       Impact factor: 2.408

Review 5.  Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.

Authors:  Karel Pacak; Graeme Eisenhofer; Ioannis Ilias
Journal:  Hormones (Athens)       Date:  2009 Apr-Jun       Impact factor: 2.885

6.  A Rare Case of Simultaneous Pheochromocytoma Accompanied with an Ileocecal Neuroendocrine Tumor.

Authors:  Karim M Eltawil; Carly Whalen; Julie N Leal; John Kelly MacDonald; Owen Prowse
Journal:  Case Rep Oncol       Date:  2022-01-24

7.  Pheochromocytoma with abdominal aortic aneurysm presenting as recurrent dyspnea, hemoptysis, and hypotension: A case report.

Authors:  Hai-Yang Zhao; Yong-Zhen Zhao; Yu-Mei Jia; Xue Mei; Shu-Bin Guo
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

8.  Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry.

Authors:  WenQi Yuan; WeiQinq Wang; Bin Cui; TingWei Su; Yan Ge; Lei Jiang; WeiWei Zhou; Guang Ning
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

9.  False Positive Radioiodinated Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor.

Authors:  Hee Soo Jung; Seok Jun Moon; Yun Mi Kim; Hye Rim Kang; Seok Mo Lee; Soo Jin Jung; Seok Jin Choi; Tae Kyoon Kim; Min Jeong Kwon; Jeong Hyun Park; Soon Hee Lee
Journal:  Case Rep Oncol Med       Date:  2015-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.